Search results
Top Studies From ESOC 2024 in Review
Medscape· 7 days agoMedscape NeurologyDiener on NeurologyCOMMENTARYTop Studies From European Stroke Organisation Congress 2024 in ReviewHans-Christoph Diener, MD, PhD...
Honing Catheter Ablation Techniques for Atrial Fibrillation
Medscape· 2 days ago...Ablation for the Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation (REAL-AF)...
Osteoarthritis Drugs Need Trials With Appropriate Endpoints
Medscape· 5 days agoFor the elusive target of disease-modifying OA drugs (DMOADs), "there have been a lot of...
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach...
Morningstar· 5 days agoPALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 6 days agoWith a safety profile comparable with that seen in adult patients, ixekizumab "met the prespecified...
In It Together: Doctor and Patient on GLP-1s
Medscape· 6 days agoEarlier this year, Fernandez found a new clinician who suggested he take a glucagon-like peptide 1 (GLP-1) receptor agonist for weight loss. When...
A New Psychotherapeutic 'Gold Standard' for Chronic Pain?
Medscape· 7 days agoA single course of treatment with emotional awareness and expression therapy (EAET) was associated...
New Study Links Tattoos With Increased Risk of Blood Cancer—Here’s What to Know
Health via Yahoo News· 4 days agoA new study found an association between having a tattoo and a heightened risk of lymphoma, but some...
Lung Cancer Screening Can Boost Early Diagnosis, Survival
Medscape· 6 days agoResearchers found a "striking association" between lung cancer screening and both earlier-stage...
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
Medscape· 5 days agoThis marks the first approval for a KRAS inhibitor to treat CRC.